Newtopia
Newtopia delivers highly personalized and targeted disease prevention solutions to reduce healthcare costs.
Launch date
Employees
Market cap
$1.3m
Enterprise valuation
$8m (Public information from Sep 2024)
Share price
CAD0.01 NEWU.V
Toronto Ontario (HQ)
Financials
Estimates*
CAD | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|---|---|---|
Revenues | 6.1m | 11.4m | 10.5m | 11.2m | 14.3m | 25.2m | 36.1m |
% growth | 99 % | 87 % | (8 %) | 7 % | 28 % | 76 % | 43 % |
EBITDA | (7.5m) | (6.6m) | (7.2m) | (6.7m) | - | - | - |
% EBITDA margin | (123 %) | (58 %) | (69 %) | (60 %) | - | - | - |
Profit | (10.1m) | (7.7m) | (7.6m) | (7.7m) | - | - | - |
% profit margin | (166 %) | (68 %) | (73 %) | (69 %) | - | - | - |
EV / revenue | - | 6.6x | 4.3x | 1.8x | 1.6x | - | - |
EV / EBITDA | - | -11.3x | -6.2x | -3.1x | - | - | - |
R&D budget | 2.5m | 3.4m | <1m | 1.4m | - | - | - |
R&D % of revenue | 41 % | 30 % | 4 % | 12 % | - | - | - |
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
$1.0m | Angel | ||
$1.1m | Angel | ||
N/A | $20.0k | Grant | |
N/A | Early VC | ||
$2.0m | Early VC | ||
$10.0m | Series A | ||
N/A | Late VC | ||
N/A | N/A | IPO | |
* | N/A | $747k | Private Placement VC |
* | CAD200k | Post IPO Debt | |
Total Funding | $14.9m |